3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
14
Leukemia, Myeloid, Acute
7
Neoplasms
3
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Neuroblastoma
2
Liver Neoplasms
2
Hepatoblastoma
2
Fibrolamellar hepatocellular carcinoma
2
Tongue Neoplasms
1
Thyroid cancer, Hurthle cell
1
Thyroid Diseases
1
Sarcoma, Myeloid
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors
1
Melanoma
1
Gastrointestinal Stromal Tumors
1
Desmoplastic Small Round Cell Tumor
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Specimen Handling
3
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Radiosurgery
2
Liver Transplantation
2
Gemcitabine
2
Cisplatin
2
Biopsy
2
tislelizumab
1
sacituzumab govitecan
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
dehydroftorafur
1
binimetinib
1
Tegafur
1
S 1 (combination)
1
Pancreatic Hormones
1
Leucovorin
1
Hydroxychloroquine
1
Cyclophosphamide
1
Cholangiopancreatography, Endoscopic Retrograde
1
Capecitabine
1
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Klatskin Tumor
×
Sorafenib
×
1 year
×
Clear all
No trials found.